Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "RET"

1729 News Found

Zota Health Care posts 83.86% revenue surge in FY26
Healthcare | May 25, 2026

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy


AbbVie signals major oncology momentum at ASCO
R&D | May 25, 2026

AbbVie signals major oncology momentum at ASCO

With standout ADC and t-cell engager response data across hard-to-treat cancers


Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
Clinical Trials | May 23, 2026

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
News | May 23, 2026

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform


APHI welcomes CCI order on integrated healthcare delivery model
Healthcare | May 22, 2026

APHI welcomes CCI order on integrated healthcare delivery model

The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices


Takeda Pharma ordered to pay $2.5 billion in Amitiza case
News | May 21, 2026

Takeda Pharma ordered to pay $2.5 billion in Amitiza case

US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance
News | May 21, 2026

Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance

The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations